GR20030100190A - Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs. - Google Patents

Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs.

Info

Publication number
GR20030100190A
GR20030100190A GR20030100190A GR2003100190A GR20030100190A GR 20030100190 A GR20030100190 A GR 20030100190A GR 20030100190 A GR20030100190 A GR 20030100190A GR 2003100190 A GR2003100190 A GR 2003100190A GR 20030100190 A GR20030100190 A GR 20030100190A
Authority
GR
Greece
Prior art keywords
derivatives
neuromeodulating
aminotetrahydrofuran
neuroregenerative
prototypical
Prior art date
Application number
GR20030100190A
Other languages
Greek (el)
Other versions
GR1004868B (en
Inventor
Αλεξανδρος Βαμβακιδης
Original Assignee
Αλεξανδρος Βαμβακιδης
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Αλεξανδρος Βαμβακιδης filed Critical Αλεξανδρος Βαμβακιδης
Priority to GR20030100190A priority Critical patent/GR1004868B/en
Publication of GR20030100190A publication Critical patent/GR20030100190A/en
Publication of GR1004868B publication Critical patent/GR1004868B/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

he invention relates to the amonitetrahydrofuran derivatives analogues of
GR20030100190A 2003-04-22 2003-04-22 Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs. GR1004868B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20030100190A GR1004868B (en) 2003-04-22 2003-04-22 Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20030100190A GR1004868B (en) 2003-04-22 2003-04-22 Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs.

Publications (2)

Publication Number Publication Date
GR20030100190A true GR20030100190A (en) 2004-12-17
GR1004868B GR1004868B (en) 2005-04-26

Family

ID=33561643

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20030100190A GR1004868B (en) 2003-04-22 2003-04-22 Aminotetrahydrofuran derivatives, muscarinic/sigma/sodium channel ligands, ortho-and allo-sterically operating, as prototypical neuromeodulating and neuroregenerative drugs.

Country Status (1)

Country Link
GR (1) GR1004868B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008087458A2 (en) * 2007-01-17 2008-07-24 Alexandre Vamvakides NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
US9180106B2 (en) 2009-02-26 2015-11-10 Anavex Life Sciences Corp. Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008087458A2 (en) * 2007-01-17 2008-07-24 Alexandre Vamvakides NEW SIGMA(σ)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
US9180106B2 (en) 2009-02-26 2015-11-10 Anavex Life Sciences Corp. Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity

Also Published As

Publication number Publication date
GR1004868B (en) 2005-04-26

Similar Documents

Publication Publication Date Title
TW200716646A (en) (S)-N-methylnaltrexone
WO2006086562A3 (en) Phenylazetidinone derivatives
MXPA03010134A (en) Substituted cyclohexane-1,4-diamine derivatives.
MXPA05009015A (en) Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament.
UA86591C2 (en) Pyrrolodihydroisoquinolines as pde10 inhibitors, pharmaceutical composition based thereon
GB2430935A (en) Tetrapeptide analogs
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200505875A (en) Novel compounds
IS2865B (en) Methods for Preparing Pharmaceutical Compositions Containing Epothilone Analogs to Treat Cancer
CY1110209T1 (en) Substituted Benzo (D) isoxazol-3-yl-amine compounds as analgesics
UA92894C2 (en) Method for the producing and use of phosphate adsorbent composition, phosphate adsorbent, and the composition therein
TW200700071A (en) Novel use
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
BR0311189A (en) Flibanserin polymorphic a-containing pharmaceutical compositions
MX2007006042A (en) Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof.
WO2005117543A3 (en) N-sulfonylcarboximidamide apoptosis promoters
ZA200604874B (en) Pharmaceutical compositions
NO20054346L (en) Compositions and methods for the prevention and treatment of endotoxin-related diseases and conditions
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
MXPA05008902A (en) Menthol solutions of drugs.
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
ZA200606422B (en) Anthelmintic composition
SE0300457D0 (en) Novel compounds
MXPA06000636A (en) Semi-solid formulations for the oral administration of taxoids.